EUCTR2011-001123-20-IT进行中（未招募）不适用
Phase 2 Multi-Center, Historically Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Revised Protocol 02 incorporating Protocol Amendment 01
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Newly diagnosed Philadelphia chromosome positive ALL - Age>1 year and < less than 18 years old - Induction chemotherapy Are the trial subjects under 18? yes
- •Number of subjects for this age range: 75
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Prior treatment with BCR-ABL inhibitor - Extrameduallary involvement of the testicles - Active systemic bacterial, fungal or viral infection - Down syndrome
研究者
相似试验
进行中（未招募）
不适用
Phase II Pediatric Philadelphia Positive Acute Lymphoblastic LeukemiaEUKEMIA, PEDIATRICMedDRA version: 16.1Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864EUCTR2011-001123-20-Outside-EU/EEABristol-Myers Squibb International Corporation90
进行中（未招募）
不适用
Phase II Pediatric Philadelphia Positive Acute Lymphoblastic LeukemiaEUKEMIA, PEDIATRICMedDRA version: 16.1Level: LLTClassification code 10000845Term: Acute lymphoblastic leukemiaSystem Organ Class: 100000004864EUCTR2011-001123-20-GBBristol-Myers Squibb International Corporation90
进行中（未招募）
不适用
A trial to compare Z102 against Prednisone in patients with rheumatoid arthritis.Treatment of patients with moderate to severe rheumatoid arthritis (RA)MedDRA version: 14.1Level: HLTClassification code 10039075Term: Rheumatoid arthritis and associated conditionsSystem Organ Class: 10021428 - Immune system disordersEUCTR2011-002392-41-BGZalicus, Inc.200
进行中（未招募）
不适用
A trial to compare Z102 against Prednisone in patients with rheumatoid arthritis.EUCTR2011-002392-41-HUZalicus, Inc.200
进行中（未招募）
不适用
A PHASE II, MULTICENTER, UNCONTROLLED, OPEN STUDY IN PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPYTO EVALUATE THE SAFETY AND EFFICACY OF A TREATMENT WITH THYMOSIN ALPHA 1 PLUS RIBAVIRIN.EUCTR2004-001927-39-ITSIGMA-TA